Does tp-Te interval predict heart rate reduction after fingolimod administration in patients with multiple sclerosis?
This study firstly demonstrates that prolonged Tp-Te interval may identify those MS patients treated with fingolimod at higher risk of having significant, asymptomatic HR reduction during clinical observation.
Calcium and magnesium changes were more pronounced in patients who received PO for bowel preparation.